Simplex Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-95
Closed -$4K 7361
2017
Q3
$4K Sell
95
-177
-65% -$595 ﹤0.01% 4699
2017
Q2
$9K Sell
272
-16
-6% -$53 ﹤0.01% 4125
2017
Q1
$2K Buy
288
+228
+380% +$887 ﹤0.01% 5496
2016
Q4
$5K Sell
60
-735
-92% -$3.03K ﹤0.01% 4473
2016
Q3
$35K Buy
795
+150
+23% +$485 ﹤0.01% 2445
2016
Q2
$16K Buy
+645
New +$2.33K ﹤0.01% 3149

Simplex Trading's AST Position: Q1 2019 in Review

Simplex Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 1,842 shares — an estimated $1K sold.

Simplex Trading first reported a position in AST in Q1 2017 and held it in 6 quarters. The position peaked at $58K in Q1 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Simplex Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 1,842 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $1K.
  • Simplex Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2017 and held it in 6 quarters.
  • Simplex Trading's Asterias Biotherapeutics Inc. Series A position peaked at $58K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.